715 CABAZITAXEL FOR METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): FINAL QUALITY OF LIFE (QOL) RESULTS WITH SAFETY DATA FROM THE UNITED KINGDOM (UK) EARLY ACCESS PROGRAMME (EAP) (NCT01254279)

Autor:	Anna Lydon, David Bottomley, Alison Birtle, Santhanam Sundar, Amit Bahl, James D. Wylie, Zafar Malik, Malcolm David Mason, Simon Chowdhury, Johann S. de Bono, Susan Masson, Robert Jones, Nicholas D. James
Rok vydání:	2013
Předmět:	Oncology Gynecology medicine.medical_specialty business.industry Urology Castration resistant medicine.disease Prostate cancer Quality of life Cabazitaxel Internal medicine medicine business medicine.drug
Zdroj:	Journal of Urology. 189
ISSN:	1527-3792 0022-5347
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::961885322b2d6e6937935a2f8b4e5add https://doi.org/10.1016/j.juro.2013.02.274 Zobrazit plný text záznamu